PROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop vial (NDC 0...
FDA Recall #D-1540-2022 — Class I — August 22, 2022
Product Description
PROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop vial (NDC 0409-4699-54) further packaged in a tray of 10 vials (NDC Carton: 0409-4699-24), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
Reason for Recall
Presence of particulate matter
Recalling Firm
Pfizer Inc. — New York, NY
Classification
Class I — Reasonable probability of serious adverse health consequences or death.
Product Type
Drugs
Product Quantity
5,390 vials
Distribution
USA Nationwide
Code Information
Lot#: EA7470, Exp 6/1/2023
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated